AlisonRaeMoliternoMD

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Moliterno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1992 - 1994
Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1989 - 1992
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1989

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

38 citations
The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.
Naveen Pemmaraju, Alison R. Moliterno, Donna M. Williams, Ophelia Rogers, Jerry L. Spivak
Leukemia. 2007-05-17
70 citations
Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis and idiopathic myelofibrosis
Donna M. Williams, Ann H. Kim, Ophelia Rogers, Jerry L. Spivak, Alison R. Moliterno
Experimental Hematology. 2007-11-01
45 citations
Two Clinical Phenotypes in Polycythemia Vera
Jerry L. Spivak, Michael Considine, Donna M. Williams, C. Conover Talbot, Ophelia Rogers
The New England Journal of Medicine. 2014-08-27

Abstracts/Posters

Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational Burden
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
ATM Germline Variant Increases the Risk of MPN Progression
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Independent Association of Male Sex with Presentation and Clinical Outcomes in Myeloproliferative Neoplasms
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
High Mobility Group A1 Chromatin Remodeling Proteins Amplify Inflammatory Networks to Drive Leukemic Transformation in Chronic Myeloproliferative Neoplasia in Humans a...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018